Netherlands Cancer Institute to use Proscia platform
Proscia, a provider of digital and computational pathology solutions, has announced that the Netherlands Cancer…
Proscia, a provider of digital and computational pathology solutions, has announced that the Netherlands Cancer…
Labiotech recently interviewed Nathan Buchbinder, chief product officer at Proscia, about digital pathology. AI has…
This week, in our last podcast of 2022, we have two guests. We have conversations…
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been…
Biopharma company, Khondrion, has marked announced improvements from patients with MELAS spectrum disorders taking its…
The approval of CSL's gene therapy Hemgenix has ushered in a new era for hemophilia…
Clinical-stage pharmaceutical company, Khondrion, discovering and developing therapies targeting primary mitochondrial diseases announced yesterday (November…
Cradle, a Dutch startup, has received €5.5 million ($5.4 million) in seed funding to further…
The biotech stock market is currently in a tough spot, with many companies facing suppressed…
Large scale production trials of the first bee-free honey will start in the New Year…
ISA Pharmaceuticals B.V, a Netherlands-based clinical stage biotech developing immunotherapies to treat cancers and infectious…